Perioperative use of renin-angiotensin system inhibitors and outcomes in patients undergoing cardiac surgery

Renin-angiotensin system inhibitors (RASi) are beneficial in several classes of cardiovascular patients. However, whether their perioperative use is beneficial and/or safe in cardiac surgery is unclear. Here the authors perform a multicenter retrospective cohort study showing that preoperative and p...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Qian Ding, Zugui Zhang, Hong Liu, Huang Nie, Mark Berguson, Jordan E. Goldhammer, Nilas Young, Douglas Boyd, Rohinton Morris, Jianzhong Sun
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
Q
Acceso en línea:https://doaj.org/article/c783183ccc1a4ff1beea61ffd8341020
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c783183ccc1a4ff1beea61ffd8341020
record_format dspace
spelling oai:doaj.org-article:c783183ccc1a4ff1beea61ffd83410202021-12-02T16:50:57ZPerioperative use of renin-angiotensin system inhibitors and outcomes in patients undergoing cardiac surgery10.1038/s41467-019-11678-92041-1723https://doaj.org/article/c783183ccc1a4ff1beea61ffd83410202019-09-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-11678-9https://doaj.org/toc/2041-1723Renin-angiotensin system inhibitors (RASi) are beneficial in several classes of cardiovascular patients. However, whether their perioperative use is beneficial and/or safe in cardiac surgery is unclear. Here the authors perform a multicenter retrospective cohort study showing that preoperative and postoperative use of RASi is associated with reduction of mortality in patients undergoing cardiac surgery.Qian DingZugui ZhangHong LiuHuang NieMark BergusonJordan E. GoldhammerNilas YoungDouglas BoydRohinton MorrisJianzhong SunNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-10 (2019)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Qian Ding
Zugui Zhang
Hong Liu
Huang Nie
Mark Berguson
Jordan E. Goldhammer
Nilas Young
Douglas Boyd
Rohinton Morris
Jianzhong Sun
Perioperative use of renin-angiotensin system inhibitors and outcomes in patients undergoing cardiac surgery
description Renin-angiotensin system inhibitors (RASi) are beneficial in several classes of cardiovascular patients. However, whether their perioperative use is beneficial and/or safe in cardiac surgery is unclear. Here the authors perform a multicenter retrospective cohort study showing that preoperative and postoperative use of RASi is associated with reduction of mortality in patients undergoing cardiac surgery.
format article
author Qian Ding
Zugui Zhang
Hong Liu
Huang Nie
Mark Berguson
Jordan E. Goldhammer
Nilas Young
Douglas Boyd
Rohinton Morris
Jianzhong Sun
author_facet Qian Ding
Zugui Zhang
Hong Liu
Huang Nie
Mark Berguson
Jordan E. Goldhammer
Nilas Young
Douglas Boyd
Rohinton Morris
Jianzhong Sun
author_sort Qian Ding
title Perioperative use of renin-angiotensin system inhibitors and outcomes in patients undergoing cardiac surgery
title_short Perioperative use of renin-angiotensin system inhibitors and outcomes in patients undergoing cardiac surgery
title_full Perioperative use of renin-angiotensin system inhibitors and outcomes in patients undergoing cardiac surgery
title_fullStr Perioperative use of renin-angiotensin system inhibitors and outcomes in patients undergoing cardiac surgery
title_full_unstemmed Perioperative use of renin-angiotensin system inhibitors and outcomes in patients undergoing cardiac surgery
title_sort perioperative use of renin-angiotensin system inhibitors and outcomes in patients undergoing cardiac surgery
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/c783183ccc1a4ff1beea61ffd8341020
work_keys_str_mv AT qianding perioperativeuseofreninangiotensinsysteminhibitorsandoutcomesinpatientsundergoingcardiacsurgery
AT zuguizhang perioperativeuseofreninangiotensinsysteminhibitorsandoutcomesinpatientsundergoingcardiacsurgery
AT hongliu perioperativeuseofreninangiotensinsysteminhibitorsandoutcomesinpatientsundergoingcardiacsurgery
AT huangnie perioperativeuseofreninangiotensinsysteminhibitorsandoutcomesinpatientsundergoingcardiacsurgery
AT markberguson perioperativeuseofreninangiotensinsysteminhibitorsandoutcomesinpatientsundergoingcardiacsurgery
AT jordanegoldhammer perioperativeuseofreninangiotensinsysteminhibitorsandoutcomesinpatientsundergoingcardiacsurgery
AT nilasyoung perioperativeuseofreninangiotensinsysteminhibitorsandoutcomesinpatientsundergoingcardiacsurgery
AT douglasboyd perioperativeuseofreninangiotensinsysteminhibitorsandoutcomesinpatientsundergoingcardiacsurgery
AT rohintonmorris perioperativeuseofreninangiotensinsysteminhibitorsandoutcomesinpatientsundergoingcardiacsurgery
AT jianzhongsun perioperativeuseofreninangiotensinsysteminhibitorsandoutcomesinpatientsundergoingcardiacsurgery
_version_ 1718383006257774592